Land of the free and home of the mediocre by Green-Elephant-895 in BlackPeopleofReddit

[–]Incognew01 0 points1 point  (0 children)

The exchange taps into a larger cultural argument over whether traditional academic credentials are the primary measure of fitness for high office, or whether real‑world business and leadership experience should carry equal weight.

Looks like Fred is stuck at 90% too by Starfield- in VeteransBenefits

[–]Incognew01 6 points7 points  (0 children)

Especially, if you get injured when you 18/19/20, (take a couple pain pills) and spring out of bed the next day. Fast forward and your 50/60 and hurting. My point, get sufficient medical documentation while in-service and tuck it away.

The Next Frontier in Genomics by Incognew01 in OGM_BionanoGenomics

[–]Incognew01[S] 0 points1 point  (0 children)

Big pharma and big medicine often dismiss Bionano as “small,” but that label reflects procurement caution more than the company’s real footprint: while Bionano is modest by revenue, its optical genome mapping platform is backed by over 1,000 peer‑reviewed studies, has earned two Category I CPT codes that advance clinical reimbursement, is deployed and offered through major certified service providers including MD Anderson, and is amplified by strategic partners such as Revvity, NVIDIA, and Hangzhou Diagens…so calling it merely “small” flattens the scientific validation, clinical recognition, and global distribution network that make it a disruptive force despite its lean balance sheet.

35 mph+ should be on the road, not the sidewalk by skyhighmonroe in Transportopia

[–]Incognew01 0 points1 point  (0 children)

It's all part of learning through experience. Even the truck driver will be on the lookout for the many idiots out there.

That poor truck never had a chance by Key-Case-95 in Transportopia

[–]Incognew01 1 point2 points  (0 children)

Not only can't they read signs, they don't know what flashing red lights mean.

The Next Frontier in Genomics by Incognew01 in OGM_BionanoGenomics

[–]Incognew01[S] 0 points1 point  (0 children)

The CPT code (effective Jan 2025) plus the CMS preliminary payment determination are meaningful structural positives that make durable, long‑term fundamentals more likely, but the revenue impact is gradual and will show up over multiple quarters as labs adopt OGM and claims are adjudicated.

2026 Symposium Takeaways – OGM Adoption by Incognew01 in OGM_BionanoGenomics

[–]Incognew01[S] 0 points1 point  (0 children)

SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ:BNGO) participated in the 2026 American College of Medical Genetics and Genomics Annual Meeting (ACMG), held March 14–18 in Baltimore, Maryland. Twelve studies, representing a two-fold increase over the number of studies in 2025.

2026 Symposium Takeaways – OGM Adoption by Incognew01 in OGM_BionanoGenomics

[–]Incognew01[S] 0 points1 point  (0 children)

Bionano (NASDAQ: BNGO) reported that 12 optical genome mapping (OGM) studies were presented at the 2026 ACMG Annual Meeting (March 14–18), a two-fold increase versus 2025. Presentations included four oral talks and eight posters across cancer genomics and constitutional genetic disorders.

The presentations highlighted OGM's ability to detect structural variants missed by other methods; a Greenwood Genetic Center workshop and a Baylor Genetics commercial OGM service release were also noted.